The New Era of Biosimilar Therapeutics for Multiple Sclerosis

Mar 22, 2024

- Mar 21, 2025

0.75

Claim your AMA PRA Category 1 Credit(s) credit

Already have an Account? Log In
Don’t have an account? Register Today

This course is available for logged in users only. Please login or register to take the course.

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Pathophysiology, Diagnosis, and ...

FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selectio...

LIVE UPDATE FROM AHA24: What do we know about antiplatelets added to anticoagulation in pa...